Atrial fibrillation (AF) is the most common sustained arrhythmia with a prevalence of less than 1% in subjects aged under 60 years and of more than 10% in those aged over 75 years. 1,2 Elevated blood pressure is one of the major risk factors for the development of AF. 3 Compared to diastolic blood pressure, high systolic blood pressure has been observed to be more closely associated with the risk of the occurrence of AF. 3 The long-term risk for new-onset AF increases along with a rising level of systolic blood pressure. 3 Furthermore, systolic blood pressure rises along with increasing arterial stiffness during the aging process, 4,5 and arterial stiffness has been found to predict future AF in hypertensive subjects. 6 Adequately performed blood pressure home measurements and blood pressure measurements performed by a nurse have a relatively good correlation with 24-hour ambulatory blood pressure (ABP) measurement; however, poor agreement has been found between routine outpatient clinic office blood pressure and ABP. 7 Nocturnal ABP has been suggested to be superior to daytime blood pressure in predicting cardiovascular risk. 8 Nighttime ABP has also been shown to be associated with atrial remodeling and neurohormonal activation in subjects with idiopathic AF. 9 Although both diurnal and nocturnal systolic blood pressure have been attributed to the risk for the onset of AF, 10 data about the relative significance of different ABP components in predicting long-term risk for new-onset AF are limited. We hypothesized that nighttime systolic ABP is an important contributor to the long-term risk of AF during aging and therefore perhaps one should put greater emphasis on its evaluation and management. To test the hypothesis, we assessed the association of baseline nighttime and daytime ABP with the development of new-onset AF requiring a hospital visit during, on average, more than 16 years of follow-up in 903 subjects resembling general population and initially aged 40 to 59 years.
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METHODS
The Oulu Project Elucidating Risk of Atherosclerosis (OPERA) study is a prospective, population-based cohort, epidemiologic follow-up study designed to address the risk factors and disease endpoints of atherosclerotic cardiovascular diseases. Between 1990 and 1993, a total of 1,045 middle-aged subjects initially aged 40 to 59 years were recruited. Hypertensive subjects were randomly selected from the national register for reimbursement of medication, and age-and sex-matched control subjects from the National Health Register. Subjects with significant heart disease were excluded from the study. Details of the study population have been described elsewhere. 11 The study subjects had thorough clinical examinations and laboratory tests at baseline. The present analysis included the subjects (n = 903; 439 with hypertension and 464 controls) who had ABP monitoring at baseline. The study was approved by the Ethical Committee of the Faculty of Medicine, University of Oulu, and was carried out according to the principles of the Declaration of Helsinki. An informed consent was obtained from each participant.
ABP measurements were obtained with a noninvasive fully automatic SpaceLabs90207 oscillometric unit (SpaceLabs, Redmond, Washington). The measurements were taken every 15 minutes from 04:00 am to 12:00 pm and every 20 minutes from 12:00 pm to 04:00 am. This yielded numerous blood pressure measurements both at nighttime and daytime clearly exceeding the minimum requirements of at least 20 valid awake and 7 valid asleep ABP measurements recommended by the European Society of Hypertension. 8 The present analysis focused on the nighttime ABP and the daytime ABP. The accuracy and reproducibility of the blood pressure readings obtained with this device have previously been settled by the British Hypertension Society and the US Association for the Advancement of Medical Instrumentation. Similarity (difference < 5 mm Hg) between 4 SpaceLabs blood pressure measurements and 4 auscultatory readings using a Y-connector was required to ensure the proper positioning of the cuff. The study subjects were instructed to relax their arm during the measurement. Systolic blood pressure values less than 70 or more than 250 mm Hg, diastolic blood pressure values less than 40 or more than 150 mm Hg, and heart rate less than 40 or more than 150 beats/min were automatically excluded from the analysis. Based on these criteria, less than 3% of the blood pressure measurements were excluded as artifacts. 12 At baseline, all the study subjects had a comprehensive clinical examination including height and weight measurements in the research laboratory of the Department of Internal Medicine, University of Oulu. The body mass index was defined as weight divided by height squared (kg/m 2 ). Alcohol consumption habits and smoking as pack-years were evaluated by standardized health questionnaires, which were completed by 2 specially trained nurses, and the details checked by a physician. The laboratory test samples were taken after an overnight fast, blood was drawn into EDTA tubes, and plasma was separated by centrifugation and stored for analysis. The routine clinical laboratory tests were analyzed in the Central Laboratory of the Oulu University Hospital as described in detail elsewhere. 11 A method based on the Jaffe reaction was used to determine the serum creatinine level. The concentration of total cholesterol was analyzed in the plasma and lipoprotein fractions by enzymatic colorimetric methods (kits of Boehringer Diagnostica, Mannheim GmbH, Germany) using a Kone Specific analyzer (Kone Specific, Selective Chemistry Analyser, Kone Instruments, Espoo, Finland). The plasma low-density lipoprotein cholesterol concentration was determined by subtracting the cholesterol concentration in the high-density lipoprotein from that in the very-low-density free fraction. C-reactive protein was analyzed using commercially available Enzyme-Linked Immunosorbent Assay (ELISA) kits (Diagnostic Systems Laboratories, TX).
The distinct endpoint of the present analysis was a new-onset AF requiring a hospital visit. AF events were obtained from the Finnish Causes-of-Death Register and the Hospital Discharge code register until the end of the year 2009. Endpoints were classified according to International Classification of Diseases revision 8 (ICD-8) or ICD-9 before 1994 and ICD-10 thereafter. The earlier verified FINRISK classification was used to classify the events. 13 Therefore, the reliability of event diagnosis data is accurate and the classification is systematic. The reliability of these registers has been previously documented. 14 The Mann-Whitney U test was used to assess the statistical significance of the differences between continuous variables and the χ 2 -test was used for categorical variables. The significance of the association of clinical and ABP parameters with the occurrence of new-onset AF after adjustments with univariable predictors of AF was evaluated in the Cox hazards model. The baseline variables, which differed at P <0.05 level between the subjects with vs. without new-onset AF during the follow-up, were entered in the multivariable Cox hazards model. The ABP and heart rate parameters, which differed significantly between the subjects with vs. without the occurrence of AF, were tested in the Cox clinical hazards model one at a time. The Kaplan-Meier survival curves were used to show the cumulative proportional probability of the occurrence of new-onset AF in subjects who were dichotomized according to a cutoff point of ABP. We determined the best cutoff point by finding a point from the receiver operating characteristics curve where the sum of the sensitivity and specificity was the largest. The log-rank test was used to assess the statistical significance of the separation of the curves. The IBM SPSS Statistics software 22.0 (Armonk, NY: IBM Corp) was used for analyzing the data. A P value <0.05 was considered to be statistically significant.
RESULTS
After an average of 16.4 ± 3.6 years of follow-up, 91 (10%) of the study subjects had experienced a new-onset AF requiring a hospital visit.
At baseline, elevated nighttime mean systolic ABP was associated with higher age, usage of antihypertensive medication such as calcium-blockers and angiotensin-converting enzyme inhibitors, larger body mass index, higher alanine aminotransferase, uric acid, fasting plasma glucose, and high-sensitivity C-reactive protein levels (Table 1) . Several baseline clinical parameters had a significant association with new-onset AF during the long-term follow-up (Table 2) . Baseline higher age, male sex, taller height, larger body mass index, smoking (more pack-years), higher levels of alanine aminotransferase, uric acid, and fasting plasma glucose all predicted the development of AF.
Of the baseline ABP monitoring variables, higher mean systolic ABP, higher daytime mean systolic ABP, higher nighttime mean systolic ABP, lower ambulatory mean heart rate, and lower ambulatory daytime mean heart rate showed a significant univariable association with the risk of development of new-onset AF during the follow-up (Table 2) . Baseline mean diastolic ABP, daytime mean diastolic ABP, and nighttime mean diastolic blood pressure were very similar in the subjects with versus without the occurrence of AF during the follow-up (Table 2) .
When the clinical parameters that had a significant univariable association with the development of new-onset AF were entered in the Cox clinical hazards model, higher age, and larger body mass index still predicted the development of AF (Table 3) . When the ABP monitoring parameters that significantly predicted the occurrence of new-onset AF in univariable analysis were entered in the Cox clinical hazards model 1 at a time, higher mean systolic ABP and higher nighttime mean systolic ABP retained their significant power in predicting new-onset AF whereas the association of daytime mean systolic ABP, lower ambulatory mean heart rate, and lower ambulatory daytime mean heart rate with the risk of AF did not remain statistically significant after adjustments (Table 4) .
The cumulative proportional probabilities of the development of new-onset AF in the subjects with higher vs. lower values of baseline nighttime and daytime mean systolic ABP are shown in Figure 1 . The separation of the curves increased continuously along the aging of the study subjects during more than 16 years of follow-up.
DISCUSSION
The main result of the present study was that the nighttime systolic blood pressure of the components of ABP monitoring had an important contribution to the long-term risk of new-onset AF during aging. The mean 24-hour systolic ABP was also associated with the occurrence of AF; however, this was mostly driven by the nighttime systolic blood pressure, as the association of the daytime mean systolic ABP with the risk of AF was lost after relevant adjustments.
Elevated blood pressure is a risk marker for future AF, and rigorous blood pressure home measurements and blood pressure measurements performed by a nurse have a relatively good correlation with 24-hour ABP measurement. 3 Consistent with these notions, we observed that the mean 24-hour systolic ABP predicted the development of new-onset AF. Our present findings showing that diastolic ABP and its components were very similar between the subjects who had and who did not have new-onset AF during the follow-up are in line with the previous observations The values are presented as mean ± SD or percentage of subjects. Abbreviations: ACE, angiotensin-converting enzyme; AF, atrial fibrillation; eGFR, estimated glomerular filtration rate; hs-CRP, high-sensitivity C-reactive protein; LDL-cholesterol, low-density lipoprotein cholesterol; NT MSABP, nighttime mean systolic ambulatory blood pressure.
which have shown that the systolic blood pressure is more important than the diastolic blood pressure for the risk of occurrence of AF. 3 The nighttime makes up a significant proportion of 24 hours and thus constitutes an important period for the influence of elevated blood pressure. It has been suggested that nighttime ABP is more important than daytime ABP for the cardiovascular risk. 8 Our present observations show that nighttime systolic ABP is a significant predictor of the long-term risk of development of AF, a finding which is emphasized by the present observation that the daytime systolic ABP did not predict the development of AF after relevant adjustments. Our findings are in line with the previous findings showing that nighttime ABP is associated with atrial remodeling and neurohumoral activation in subjects with idiopathic AF. 9 In our present study population, it took approximately 6 years before the risk for the occurrence of AF started to increase in those with elevated nighttime systolic ABP, suggesting that the influence of nighttime systolic blood pressure on atrial remodeling is a long process. During aging, arterial stiffness increases along with rising systolic blood pressure, 4, 5 which also contributes to the elevated risk for the occurrence of AF. 6 We observed that baseline lower ambulatory mean heart rate and lower ambulatory daytime mean heart rate were associated with long-term risk of AF; however, they lost their significant predictive power after adjustments with other risk markers. Elevated resting heart rate has been attributed to increased risk for cardiovascular disease and mortality. 16, 17 However, resting bradycardia has been shown to predict AF in male athletes. 18 In agreement with our present observations of ambulatory heart rate, there are previous data to show that a low heart rate on a moderate workload is a risk marker for the future occurrence AF in middle-aged men. 19 The values are presented as mean ± SD or percentage of subjects. Abbreviations: ABP, ambulatory blood pressure; ACE, angiotensinconverting enzyme; AF, atrial fibrillation; eGFR, estimated glomerular filtration rate; hs-CRP, high-sensitivity C-reactive protein; LDL-cholesterol, low-density lipoprotein cholesterol.
In the present analysis, several well-known risk factors of AF also predicted AF. Higher age, male sex, taller height, baseline larger body mass index, smoking history, higher alanine aminotransferase, uric acid, and fasting plasma glucose levels were all associated with the long-term risk of newonset AF. Several of these factors, such as higher age, larger body mass index, higher alanine aminotransferase, uric acid, and fasting plasma glucose levels, were also associated with elevated nighttime systolic ABP. After adjustment with other risk indicators in a multivariable model, higher age and larger body mass index still predicted the occurrence of AF. The importance of age as a major risk indicator of the development of AF has been proven in several large-scale studies. [20] [21] [22] Our present observations concur with this concept by showing that higher age independently contributed to the risk of the occurrence of AF. Our present findings are also in alignment with the previous observations which have shown that large body mass index indicating obesity is a strong risk marker for AF. [23] [24] [25] [26] Male sex, 20, 22 taller height, 27, 28 smoking, [29] [30] [31] [32] elevated alanine aminotransferase, 33 uric acid, [34] [35] [36] [37] and fasting plasma glucose 38 levels are also well-established risk factors for AF.
Our study has some limitations. We did not perform repeated ABP monitoring during the 16 years of follow-up.
However, as blood pressure is a well-established risk marker for AF, we focused on clarifying the contribution of different baseline ABP components to the long-term risk of new-onset AF. The endpoint of the present analysis was a new-onset AF requiring a hospital visit. The endpoint can be considered distinct and the data were obtained from reliable hospital records. The AF endpoint included both patients with AF who visited the hospital emergency room or who were hospitalized. The patients with acute new-onset AF are usually referred or come to the hospital emergency room for check-up and treatment. However, it is possible that some cases with AF who did not visit a hospital may have been missed, as may those with an asymptomatic short AF episode. Sleep quality has an influence on nocturnal blood pressure and obstructive sleep apnea is known to contribute to development of AF. Unfortunately, we did not have an opportunity to measure or control sleep quality during the ABP measurements. There are dozens of risk factors for the development of AF, and we were not able to adjust the ABP components for all possible risk markers. However, that did not compromise the comparison of the contribution of different ABP components in relation to each other to the longterm risk of new-onset AF. The number of study participants was relatively small, and we were therefore unable to reliably When the baseline clinical risk markers, which differed at P < 0.05 level between the subjects with vs. without new-onset atrial fibrillation during the follow-up (age, sex, height, body mass index, smoking [pack-years], alanine aminotransferase, uric acid, and fasting plasma glucose), were entered in the multivariable Cox hazards model, age, and body mass index retained their significant predictive power for the occurrence of AF. Abbreviations: ALAT, alanine aminotransferase; CIs, confidence intervals; HR, hazards ratio; hs-CRP, high-sensitivity C-reactive protein. When the baseline clinical risk markers, which differed at P <0.05 level between the subjects with vs. without new-onset atrial fibrillation during the follow-up (age, sex, body mass index, height, smoking [pack-years], alanine aminotransferase, uric acid, and fasting plasma glucose), were entered in the multivariable Cox hazards model, age, and body mass index retained their significant predictive power for the occurrence of AF. The ambulatory blood pressure and heart rate parameters, which differed significantly between the subjects with versus without the occurrence of atrial fibrillation, were tested in the final Cox clinical hazards model one at a time. Abbreviations: ABP, ambulatory blood pressure; CIs, confidence intervals; HR, hazards ratio; MAHR, mean ambulatory heart rate; MSABP, mean systolic ambulatory blood pressure.
perform subanalyses in the study subjects who were and who were not on antihypertensive medication at baseline.
In conclusion, of the baseline ABP monitoring components, the nighttime systolic blood pressure has the closest association with the long-term risk of new-onset AF during aging. If our findings can be confirmed in future larger studies, it would be important to further assess whether nighttime systolic blood pressure requires more attention when evaluating elevated blood pressure and applying antihypertensive treatment. It should also be studied whether lowering nighttime systolic blood pressure reduces the burden of AF during aging.
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